Keywords: Generic Wellbutrin, Bupropion, Teva, Impax, GlaxoSmithKline, USA, FDA, Non-bioequivalence, Antidepressant

Teva/Impax generic Wellbutrin XL 300mg pulled from US market on non-bioequivalence grounds

Article | 04 October 2012

Print This

Following a review of new data, the US Food and Drug Administration says these indicate that Budeprion XL 300mg (bupropion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in